Medical Equipment

Global In-Situ Hybridization Market Size and Forecast to 2029: Revenue, Growth, and Trends

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the in-situ hybridization market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The In-Situ Hybridization Market Size Today And What Will Its Value Be At The End Of 2029?

The in situ hybridization market has seen strong growth in recent years. It is projected to expand from $1.68 billion in 2024 to $1.81 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.1%. The growth observed in the historic period can be attributed to factors such as early adoption in research, the evolution of molecular biology tools, the development of diagnostic applications, a shift in biomedical research focus, and increasing investment in biotechnology.

The in situ hybridization market is poised for significant expansion in the coming years. Projections indicate a rise to $2.76 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.1%. This anticipated growth during the forecast period is driven by factors such as increased integration into clinical diagnostics, an uptick in research and development funding, the emergence of automation and high-throughput solutions, and broader applications across neuroscience and pathology. Key trends anticipated during this period encompass progress in molecular biology, escalating demand within research applications, an expansion of diagnostic uses, the growing need for personalized medicine, and enhanced financial support for biomedical research.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp

Which Key Drivers Are Powering Growth In The In-Situ Hybridization Market?

The in-situ hybridization market is anticipated to experience growth as infectious diseases become more common. These conditions are characterized by their transmission from one person to another through contaminated food and beverages, or by pathogens such as viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) plays a role by identifying complementary nucleic acid sequences within tissues, utilizing labeled nucleic acid sequences (probes) specific to the infectious organism, thus driving the expansion of the in-situ hybridization market due to increasing infectious diseases. For illustration, the Centers for Disease Control and Prevention, a US-based government agency, reported in March 2024 that tuberculosis cases climbed from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases. This demonstrates how the escalation of infectious diseases is indeed stimulating the development of the in-situ hybridization market.

Which Segment Categories Are Driving Maximum Growth In The In-Situ Hybridization Market?

The in situ hybridizationmarket covered in this report is segmented –

1) By Product: Analytical Instruments, Kits and Reagents, Software and Services, Other Products

2) By Technique: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ hybridization (CISH)

3) By Probe: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)

4) By Application: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Other Applications

5) By End Use: Research And Diagnostic Laboratories, Contract Research Organization (CROs), Academic Institutes, Other End Uses

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Imaging Systems, Hybridization Systems

2) By Kits and Reagents: Hybridization Kits, Detection Kits, Probes And Reagents

3) By Software and Services: Image Analysis Software, Data Management Software, Consulting And Support Services

4) By Other Products: Accessories, Control Samples, Maintenance Supplies

What Key Trends Are Driving Growth In The In-Situ Hybridization Market?

Leading companies in the in situ hybridization market are focused on creating innovative solutions, such as RNA detection assays, to advance the development of gene therapy. An RNA detection assay is a molecular technique used to identify and quantify specific RNA molecules in a sample, facilitating the study of gene expression, viral infections, and other RNA-related biological processes. For instance, in January 2023, Bio-Techne Corporation, a US-based life sciences company, launched the RNAscope Plus smRNA-RNA detection assay. This RNAscope Plus smRNA-RNA detection assay is an advanced in situ hybridization tool designed for the simultaneous fluorescent detection of small regulatory RNAs, like microRNAs (miRNAs), along with three target RNAs or RNA biomarkers in the same tissue section. The assay offers single-cell and subcellular resolution, empowering researchers to effectively assess the biodistribution and functionality of innovative gene therapies and endogenous regulatory RNAs. It is built for scalability to support large studies and can be utilized on the Leica Bond Rx platform or as a manual assay. By integrating proprietary RNAscope and miRNAscope technologies, this assay significantly enhances the understanding of gene expression and cellular reactions, providing critical insights for developing customized gene therapies for inherited or acquired diseases.

Who Are The Leading Companies Driving The In-Situ Hybridization Market?

Major companies operating in the in situ hybridization market include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Abnova Corporation, Qiagen, Bio-Techne Corporation, Biochain Institute Inc., Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, FISH Technologies Sdn Bhd, Genetix Biotech Asia Pvt. Ltd., Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, Molecular Devices LLC., NanoString Technologies Inc., Visiopharm A/S

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

Which Region Holds The Largest Share In The In-Situ Hybridization Market Today?

North America was the largest region in the in situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp

Browse Through More Reports Similar to the Global In-Situ Hybridization Market 2025, By The Business Research Company

Hybrid Cloud Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hybrid-cloud-global-market-report

Hybrid Valve Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hybrid-valve-global-market-report

Hybrid Composites Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hybrid-composites-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795